Skip to main content

Table 3 Haematocrit and haemoglobin on different study days

From: Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

Day

Haematocrit

Haemoglobin

 

Control

Group A

Group B

Control

Group A

Group B

0

28.3 ± 3.7

28.2 ± 3.7

28.4 ± 2.8

9.2 ± 1.3

9.3 ± 1.2

9.2 ± 0.9

3

27.9 ± 3.7

26.7 ± 5.0

28.2 ± 3.7

9.1 ± 1.3

9.0 ± 1.1

9.1 ± 1.2

7

28.4 ± 4.1

28.4 ± 3.7

29.5 ± 4.0

9.1 ± 1.4

9.2 ± 1.2

9.5 ± 1.3

10

28.8 ± 4.5

29.4 ± 4.1

30.3 ± 4.2*

9.4 ± 1.6

9.6 ± 1.2

9.7 ± 1.4

14

28.8 ± 4.5

30.8 ± 4.5

32.3 ± 5.4*

9.4 ± 1.4

10.0 ± 1.5

10.3 ± 1.9*

21

29.4 ± 6.2

31.9 ± 5.0

36.5 ± 6.3* †

9.7 ± 2.0

10.3 ± 1.7

11.3 ± 2.1*

28

30.4 ± 4.5

33.3 ± 5.3

37.5 ± 5.8* †

9.9 ± 1.5

10.6 ± 1.9

11.6 ± 1.9*

  1. Shown are mean ± standard deviation values for haematocrit and haemoglobin on different study days. *P < 0.05 versus control; †P < 0.05 versus group A.